EYE21Project ID: 761792
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
H2020-EU.3.1.4. - Active ageing and self-management of health
H2020-EU.3.1.6. - Health care provision and integrated care
EYE2021. Glasses to see with 3D sound, arrival to market.
Total cost:EUR 71 429
EU contribution:EUR 50 000
Topic(s):SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
Call for proposal:H2020-SMEINST-1-2016-2017See other projects for this call
Funding scheme:SME-1 - SME instrument phase 1
EYE21 is a stereovision device capable of acquire 3D information and transform it on a sound map. This Sound Map is perceived by the brain as a 3D shape. The use of this system for Blind users allows them to recognize obstacles, shapes, distances and lets them increase their mobility.
The overall objective of the proposal is to allow blind people perceive their surroundings using EYE21 cognitive capability in order to increase their mobility and independence.
EYE21 is an evolution of more than 10 years of previous research and experiences, as it was the EU project CASBLIP.
EYE21 device is able to help blind people by different modes of working which are:
- Aid for walking. It is a natural “cognitive” way were the shapes obtained with the cameras are substituted by a “natural sound”
- Image processing tools through image recognition techniques used for reading, finding objects and face identification.
EYE21 is ready to market, it has been tested, validated, and ready to run over a smartphone. EYE21 has been developed, tested and redefined until its acceptance with 20 Blind Users. EYE21 has been tested in indoor and outdoor conditions. On this project the answer of how to industrialize and the procedure to arrive correctly to the end-users will be defined in order to reach TRL9.
The specific objectives of the project need to define the arrival to market due to the novelty of the device. It has to be deliver to the blind on the best way to have success. Also it is necessary to confirm an adequate target price and the manufacture cost. And of course the channels for arriving to the maximum market by adequate channels need to be defined.
EYE21 is a revolutionary product able to recover the seen capability to blind people with a non-invasive action. The product has been tested and developed with end users and is time to move ahead for going correctly to market. The adequate and precise plan for the next steeps is the objective of this proposal.
EU contribution: EUR 50 000
CALLE JULIAN PENA, NUM. 5 PUERTA 5